The new Karizoo Laboratories newsletter
CITRAMOX® L.A. 150 mg/ml suspension for injection
Laboratorios Karizoo S.A introduces CITRAMOX® L.A. 150 mg/ml suspension for injection HIGHLY FLUID for cattle and pigs on the nacional and internacional market.
Indicated for the treatment of respiratoy infections.
Withdrawal…
HALOFUSOL® 0,5 mg/ml oral solution
Laboratorios Karizoo S.A introduces HALOFUSOL® 0,5 mg/ml oral solution on the nacional and internacional market.
The enemy of bovine cryptosporidiosis.
Proven preventive and curative efficacy in calves.
Withdrawal period: 13 days.
Packaging:…
Alivira Spain expands its international presence with Urixine®
Alivira Spain continues its international expansion with the launch of its phenylpropanolamine-based product in several European countries. Following its successful establishment in Spain and Russia, the company will introduce Uristop®, under…
GLOBAL FORMULATION CONVENTION
From May 27 to 30, the Alivira group held the second Global Formulation Convention in Antalya, Turkey. More than 40 participants from different countries and continents gathered in Turkey for this annual meeting.
It was 4 days of work meetings,…
Alivira Animal Health Award winner 2020
We are happy & proud to announce that, second time in a row, Alivira has been awarded ‘The best company award from India/ Middle East/ Africa’ for 2020 by Animal Pharm.
Animal Pharm is a leading news and analysis service for the global…
COMPANIES REPRESENTED IN SPAIN
Laboratorios Karizoo S.A.
An Alivira Group Company
P. I. La Borda Mas Pujades 11-12
Oficina y logística
P. I. La Borda, Borges Blanques 21-25
08140 Caldes de Montbui
Barcelona (España)
T +34 938 654 148
F +34 938 654 648
www.alivira.es
karizoo@alivira.es
Communication in case of adverse events with Karizoo products: pharmacovigilance@alivira.es